Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD), the neurofibrillary tangles, and is therefore of major interest as an indicator of disease mechanisms. Many of the unusual properties of Tau can be explained by its nature as a natively unfolded protein. Examples are the large number of structural conformations and biochemical modifications (phosphorylation, proteolysis, glycosylation, and others), the multitude of interaction partners (mainly microtubules, but also other cytoskeletal proteins, kinases, and phosphatases, motor proteins, chaperones, and membrane proteins). The pathological aggregation of Tau is counterintuitive, given its high solubility, but can be rationalized by short hydrophobic motifs forming β structures. The aggregation of Tau is toxic in cell and animal models, but can be reversed by suppressing expression or by aggregation inhibitors. This review summarizes some of the structural, biochemical, and cell biological properties of Tau and Tau fibers. Further aspects of Tau as a diagnostic marker and therapeutic target, its involvement in other Tau-based diseases, and its histopathology are covered by other chapters in this volume.

[1]  Henrik Zetterberg,et al.  Fluid biomarkers in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[2]  B. Ghetti,et al.  Frontotemporal dementia: implications for understanding Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[3]  Veeranna,et al.  Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments , 2011, Neurobiology of Aging.

[4]  D. Holtzman,et al.  In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice , 2011, The Journal of Neuroscience.

[5]  J. Trojanowski,et al.  Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. , 2011, Cold Spring Harbor perspectives in medicine.

[6]  I. Landrieu,et al.  Systematic Identification of Tubulin-interacting Fragments of the Microtubule-associated Protein Tau Leads to a Highly Efficient Promoter of Microtubule Assembly* , 2011, The Journal of Biological Chemistry.

[7]  Jason T. Stevens,et al.  Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.

[8]  A. Andreadis,et al.  Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.

[9]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[10]  J. Trojanowski,et al.  The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.

[11]  E. Weeber,et al.  The Hsp90 Kinase Co-chaperone Cdc37 Regulates Tau Stability and Phosphorylation Dynamics* , 2011, The Journal of Biological Chemistry.

[12]  G. Drewes,et al.  The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner , 2011, The Journal of cell biology.

[13]  Rudi D'Hooge,et al.  Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.

[14]  E. Mandelkow,et al.  Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.

[15]  H. Soininen,et al.  Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease , 2011, Progress in Neurobiology.

[16]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[17]  E. Yaksi,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[18]  E. Mandelkow,et al.  Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.

[19]  E. Mandelkow,et al.  Tau protein and tau aggregation inhibitors , 2010, Neuropharmacology.

[20]  P. Dolan,et al.  The role of tau kinases in Alzheimer's disease. , 2010, Current opinion in drug discovery & development.

[21]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[22]  Markus Tolnay,et al.  The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.

[23]  Wendy R. Sanhai,et al.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.

[24]  Daniel J. Muller,et al.  Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability* , 2010, The Journal of Biological Chemistry.

[25]  E. Rhoades,et al.  The role of the lipid bilayer in tau aggregation. , 2010, Biophysical journal.

[26]  Jürgen Götz,et al.  Dissecting Toxicity of Tau and β-Amyloid , 2010, Neurodegenerative Diseases.

[27]  M. Schumacher,et al.  A role for FKBP52 in Tau protein function , 2010, Proceedings of the National Academy of Sciences.

[28]  J. Buchner,et al.  The Hsp90 Cochaperone, FKBP51, Increases Tau Stability and Polymerizes Microtubules , 2010, The Journal of Neuroscience.

[29]  Lawrence Rajendran,et al.  The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.

[30]  Frank Bradke,et al.  Control of neuronal polarity and plasticity--a renaissance for microtubules? , 2009, Trends in cell biology.

[31]  E. Mandelkow,et al.  Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.

[32]  J. Bamburg,et al.  Activated Actin-Depolymerizing Factor/Cofilin Sequesters Phosphorylated Microtubule-Associated Protein during the Assembly of Alzheimer-Like Neuritic Cytoskeletal Striations , 2009, The Journal of Neuroscience.

[33]  N. Gusev,et al.  Phosphorylation of more than one site is required for tight interaction of human tau protein with 14‐3‐3ζ , 2009, FEBS letters.

[34]  H. Neumann,et al.  Accumulation of tau induced in neurites by microglial proinflammatory mediators , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Tsuyoshi Morita,et al.  Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.

[36]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[37]  J. Götz,et al.  Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.

[38]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[39]  F. LaFerla,et al.  Relevance of Transgenic Mouse Models to Human Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[40]  M. Wolfe Tau Mutations in Neurodegenerative Diseases* , 2009, Journal of Biological Chemistry.

[41]  Bradley T. Hyman,et al.  Tau pathophysiology in neurodegeneration: a tangled issue , 2009, Trends in Neurosciences.

[42]  Christian Griesinger,et al.  Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.

[43]  I. Grundke‐Iqbal,et al.  Mechanisms of tau-induced neurodegeneration , 2009, Acta Neuropathologica.

[44]  V. Uversky,et al.  Function and structure of inherently disordered proteins. , 2008, Current opinion in structural biology.

[45]  W. Engel,et al.  Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains , 2008, Acta Neuropathologica.

[46]  Patrizia LoPresti,et al.  Truncated Tau with the Fyn‐binding domain and without the microtubule‐binding domain hinders the myelinating capacity of an oligodendrocyte cell line , 2008, Journal of neurochemistry.

[47]  Dmitri I Svergun,et al.  Domain conformation of tau protein studied by solution small-angle X-ray scattering. , 2008, Biochemistry.

[48]  J. Kuret,et al.  Two motifs within the tau microtubule‐binding domain mediate its association with the hsc70 molecular chaperone , 2008, Journal of neuroscience research.

[49]  E. Mandelkow,et al.  Tau-based treatment strategies in neurodegenerative diseases , 2008, Neurotherapeutics.

[50]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[51]  M. Zvelebil,et al.  Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.

[52]  D. Hanger,et al.  Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  A. Delacourte,et al.  Biochemistry of Tau in Alzheimer’s disease and related neurological disorders , 2008, Expert review of proteomics.

[54]  A. Singleton,et al.  The HapMap: charting a course for genetic discovery in neurological diseases. , 2008, Archives of neurology.

[55]  Ram Dixit,et al.  Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.

[56]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[57]  E. Elliott,et al.  BAG-1 Associates with Hsc70·Tau Complex and Regulates the Proteasomal Degradation of Tau Protein* , 2007, Journal of Biological Chemistry.

[58]  J. Luchsinger,et al.  Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms , 2007, The Journal of Neuroscience.

[59]  E. Mandelkow,et al.  Inhibition of tau aggregation in cell models of tauopathy. , 2007, Current Alzheimer research.

[60]  M. Goedert,et al.  Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.

[61]  William J Ray,et al.  Beyond amyloid: the next generation of Alzheimer's disease therapeutics. , 2007, Molecular interventions.

[62]  E. Mandelkow,et al.  Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons , 2007, The Journal of Neuroscience.

[63]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[64]  G. Schellenberg,et al.  SUT-1 enables tau-induced neurotoxicity in C. elegans. , 2007, Human molecular genetics.

[65]  Kit-Yi Leung,et al.  Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.

[66]  R. Berry,et al.  Nitration in neurodegeneration: deciphering the "Hows" "nYs". , 2007, Biochemistry.

[67]  C. Schmidt,et al.  Tau protein binding forms a 1 nm thick layer along protofilaments without affecting the radial elasticity of microtubules. , 2007, Journal of structural biology.

[68]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[69]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[70]  R. Nelson,et al.  Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.

[71]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[72]  E. Mandelkow,et al.  Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.

[73]  A. Myers,et al.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts , 2007, Neurobiology of Disease.

[74]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[75]  I. Landrieu,et al.  NMR investigation of the interaction between the neuronal protein tau and the microtubules. , 2007, Biochemistry.

[76]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[77]  Tudor A. Fulga,et al.  Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.

[78]  I. Grundke‐Iqbal,et al.  Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention , 2007, Journal of cellular and molecular medicine.

[79]  Jürgen Götz,et al.  A Decade of Tau Transgenic Animal Models and Beyond , 2007, Brain pathology.

[80]  T. Arendt,et al.  Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons – implications for Alzheimer's disease , 2007, The European journal of neuroscience.

[81]  R. Langen,et al.  Side Chain-dependent Stacking Modulates Tau Filament Structure* , 2006, Journal of Biological Chemistry.

[82]  D. Geschwind,et al.  A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration , 2006, Neuron.

[83]  S. Halpain,et al.  The MAP1 family of microtubule-associated proteins , 2006, Genome Biology.

[84]  C. Gong,et al.  Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting , 2006, The European journal of neuroscience.

[85]  H. Steinhoff,et al.  Global hairpin folding of tau in solution. , 2006, Biochemistry.

[86]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[87]  W. Noble,et al.  Molecular motors implicated in the axonal transport of tau and α-synuclein , 2005, Journal of Cell Science.

[88]  L. Buée,et al.  Regions of Tau Implicated in the Paired Helical Fragment Core as Defined by NMR , 2005, Chembiochem : a European journal of chemical biology.

[89]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[90]  Andrea Musacchio,et al.  Defining Cdk5 ligand chemical space with small molecule inhibitors of tau phosphorylation. , 2005, Chemistry & biology.

[91]  Christian Griesinger,et al.  Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions* , 2005, Journal of Biological Chemistry.

[92]  Adriana B Ferreira,et al.  The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.

[93]  I. Grundke‐Iqbal,et al.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. , 2005, The American journal of pathology.

[94]  C. Chirita,et al.  Triggers of full-length tau aggregation: a role for partially folded intermediates. , 2005, Biochemistry.

[95]  E. Mandelkow,et al.  Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells* , 2005, Journal of Biological Chemistry.

[96]  G. Johnson,et al.  Tau phosphorylation: physiological and pathological consequences. , 2005, Biochimica et biophysica acta.

[97]  John Q Trojanowski,et al.  Transgenic animal models of tauopathies. , 2005, Biochimica et biophysica acta.

[98]  N. Shahani,et al.  Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.

[99]  Y. Han,et al.  14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. , 2004, Molecules and cells.

[100]  M. Rasenick,et al.  Tau interaction with microtubules in vivo , 2004, Journal of Cell Science.

[101]  M. Jordan,et al.  New Microtubule / Tubulin-Targeted Anticancer Drugs and Novel Chemotherapeutic Strategies , 2004, Journal of chemotherapy.

[102]  E. Mandelkow,et al.  MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons , 2004, The Journal of cell biology.

[103]  D. Bennett,et al.  Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease , 2004, The Journal of Neuroscience.

[104]  Y. Ihara,et al.  Molecular aging of tau: disulfide‐independent aggregation and non‐enzymatic degradation in vitro and in vivo , 2004, Journal of neurochemistry.

[105]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[106]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[107]  Ralf Langen,et al.  Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[108]  C. Cotman,et al.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.

[109]  Ronald A Milligan,et al.  Mechanism of microtubule stabilization by doublecortin. , 2004, Molecular cell.

[110]  P. Tittmann,et al.  Surface-decoration of microtubules by human tau. , 2004, Journal of molecular biology.

[111]  S. Feinstein,et al.  Evidence for two distinct binding sites for tau on microtubules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Kenneth S. Kosik,et al.  Binding of Tau to Heat Shock Protein 27 Leads to Decreased Concentration of Hyperphosphorylated Tau and Enhanced Cell Survival* , 2004, Journal of Biological Chemistry.

[113]  John Hardy,et al.  CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .

[114]  S. Halpain,et al.  MAP2c, but Not Tau, Binds and Bundles F-Actin via Its Microtubule Binding Domain , 2004, Current Biology.

[115]  Steven P. Gygi,et al.  CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.

[116]  L. Buée,et al.  The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. , 2004, Biochemistry.

[117]  E. Mandelkow,et al.  Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. , 2004, Biochemistry.

[118]  P. Coleman,et al.  Synaptic slaughter in Alzheimer’s disease , 2003, Neurobiology of Aging.

[119]  J. Trojanowski,et al.  Proteasome Inhibition Stabilizes Tau Inclusions in Oligodendroglial Cells that Occur after Treatment with Okadaic Acid , 2003, The Journal of Neuroscience.

[120]  N. Hirokawa,et al.  Microtubules provide directional cues for polarized axonal transport through interaction with kinesin motor head , 2003, The Journal of cell biology.

[121]  Tony Hunter,et al.  Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.

[122]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Leslie Wilson,et al.  Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  C. Chirita,et al.  Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro* , 2003, Journal of Biological Chemistry.

[125]  Michel Goedert,et al.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[126]  N. Volkmann,et al.  Microscopic evidence for a minus‐end‐directed power stroke in the kinesin motor ncd , 2002, The EMBO journal.

[127]  E. Mandelkow,et al.  Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. , 2002, Molecular biology of the cell.

[128]  Stella Aronov,et al.  Visualization of translated tau protein in the axons of neuronal P19 cells and characterization of tau RNP granules , 2002, Journal of Cell Science.

[129]  E. Mandelkow,et al.  Single‐molecule investigation of the interference between kinesin, tau and MAP2c , 2002, The EMBO journal.

[130]  N. Hirokawa,et al.  MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction , 2002, The Journal of cell biology.

[131]  S. Halpain,et al.  MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments , 2002, The Journal of cell biology.

[132]  H. Paudel,et al.  Glycogen Synthase Kinase-3β Is Complexed with Tau Protein in Brain Microtubules* , 2002, The Journal of Biological Chemistry.

[133]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[134]  J. Trotter,et al.  Process Outgrowth of Oligodendrocytes Is Promoted by Interaction of Fyn Kinase with the Cytoskeletal Protein Tau , 2002, The Journal of Neuroscience.

[135]  E. Mandelkow,et al.  Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.

[136]  J. Trojanowski,et al.  Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments , 2001, The Journal of Neuroscience.

[137]  D. Cleveland,et al.  Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. , 2001, Current opinion in cell biology.

[138]  E. Mandelkow,et al.  Nonsaturable Binding Indicates Clustering of Tau on the Microtubule Surface in a Paired Helical Filament-like Conformation* , 2000, The Journal of Biological Chemistry.

[139]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[140]  H. Paudel,et al.  14-3-3ζ Is an Effector of Tau Protein Phosphorylation* , 2000, The Journal of Biological Chemistry.

[141]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[142]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Masahide Kikkawa,et al.  15 Å Resolution Model of the Monomeric Kinesin Motor, KIF1A , 2000, Cell.

[144]  G. Bloom,et al.  Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules , 1999, The Journal of Biological Chemistry.

[145]  P. Højrup,et al.  α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.

[146]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[147]  E. Mandelkow,et al.  Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. , 1999, Biochemistry.

[148]  E. Nogales,et al.  High-Resolution Model of the Microtubule , 1999, Cell.

[149]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[150]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[151]  M. Mercken,et al.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[152]  E. Mandelkow,et al.  Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. , 1998, Biochemistry.

[153]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[154]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[155]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[156]  E. Mandelkow,et al.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.

[157]  E. Mandelkow,et al.  Image Reconstructions of Microtubules Decorated with Monomeric and Dimeric Kinesins: Comparison with X-Ray Structure and Implications for Motility , 1998, The Journal of cell biology.

[158]  E. Mandelkow,et al.  X-ray structure of motor and neck domains from rat brain kinesin. , 1997, Biochemistry.

[159]  D. Wilson,et al.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.

[160]  G. Drewes,et al.  MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption , 1997, Cell.

[161]  D. Hanger,et al.  Oxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures , 1997 .

[162]  P. Markiewicz,et al.  Paired Helical Filaments Are Twisted Ribbons Composed of Two Parallel and Aligned Components: Image Reconstruction and Modeling of Filament Structure Using Atomic Force Microscopy , 1997, Journal of neuropathology and experimental neurology.

[163]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.

[164]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[165]  J. Ávila,et al.  Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .

[166]  Y. Ihara,et al.  τ Is Widely Expressed in Rat Tissues , 1996 .

[167]  K. Kosik,et al.  The pool of map kinase associated with microtubules is small but constitutively active. , 1996, Molecular biology of the cell.

[168]  N. Hirokawa,et al.  Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons , 1996, The Journal of cell biology.

[169]  M. Mercken,et al.  Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[170]  R. Brandt,et al.  Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain , 1995, The Journal of cell biology.

[171]  P. Lopresti,et al.  Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[172]  L. Binder,et al.  Polymerization of Microtubule-associated Protein Tau under Near-physiological Conditions (*) , 1995, The Journal of Biological Chemistry.

[173]  E. Mandelkow,et al.  Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[174]  J. Trojanowski,et al.  Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*) , 1995, The Journal of Biological Chemistry.

[175]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[176]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[177]  E. Mandelkow,et al.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. , 1994, The Journal of biological chemistry.

[178]  J. Ávila,et al.  Analysis of microtubule-associated protein tau glycation in paired helical filaments. , 1994, The Journal of biological chemistry.

[179]  E. Mandelkow,et al.  Domains of tau protein and interactions with microtubules. , 1994, Biochemistry.

[180]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[181]  D. Teplow,et al.  Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation. , 1994, The Journal of biological chemistry.

[182]  S. Feinstein,et al.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau , 1994, The Journal of cell biology.

[183]  R. Crowther,et al.  Assembly of Alzheimer‐like filaments from full‐length tau protein , 1994, FEBS letters.

[184]  Khadija Iqbal,et al.  Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. , 1993, The Journal of biological chemistry.

[185]  A. Matus,et al.  An isoform of microtubule-associated protein 2 (MAP2) containing four repeats of the tubulin-binding motif. , 1993, Journal of cell science.

[186]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[187]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[188]  N. Hirokawa,et al.  Dynamics of microtubules bundled by microtubule associated protein 2C (MAP2C) , 1993, The Journal of cell biology.

[189]  G. Drewes,et al.  Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau , 1992, FEBS letters.

[190]  N. Hirokawa,et al.  Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons , 1992, Nature.

[191]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[192]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[193]  E. Mandelkow,et al.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[194]  R. Liem,et al.  Primary structure of high molecular weight tau present in the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[195]  E. Mandelkow,et al.  The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.

[196]  R. Crowther,et al.  Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[197]  M. Kirschner,et al.  Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.

[198]  R. Crowther Straight and paired helical filaments in Alzheimer disease have a common structural unit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[199]  L. Binder,et al.  Identification of nuclear tau isoforms in human neuroblastoma cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[200]  M. Kirschner,et al.  Phosphorylation of microtubule‐associated protein tau: identification of the site for Ca2(+)‐calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. , 1990, The EMBO journal.

[201]  R. Vallee,et al.  Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins , 1990, Nature.

[202]  R. Maccioni,et al.  Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau , 1990, Molecular and Cellular Biochemistry.

[203]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[204]  M. Kirschner,et al.  Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains , 1989, Molecular and cellular biology.

[205]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[206]  A. Himmler Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.

[207]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[208]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[209]  N. Hirokawa,et al.  Tau proteins: the molecular structure and mode of binding on microtubules , 1988, The Journal of cell biology.

[210]  R. Crowther,et al.  Structural characterization of the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[211]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[212]  J. Baudier,et al.  Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II. , 1988, The Journal of biological chemistry.

[213]  M. Kirschner,et al.  The primary structure and heterogeneity of tau protein from mouse brain. , 1988, Science.

[214]  D. Koshland,et al.  Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C. , 1987, Biochemistry.

[215]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[216]  M. Kirschner,et al.  Tau protein function in living cells , 1986, The Journal of cell biology.

[217]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[218]  H. Ponstingl,et al.  Common and distinct tubulin binding sites for microtubule-associated proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[219]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[220]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[221]  S. Mirra,et al.  Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[222]  D. Dickson,et al.  A neuronal antigen in the brains of Alzheimer patients. , 1986, Science.

[223]  R. Crowther,et al.  Image reconstruction of the Alzheimer paired helical filament. , 1985, The EMBO journal.

[224]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[225]  R. Williams,et al.  Microtubule-associated proteins connect microtubules and neurofilaments in vitro. , 1984, Biochemistry.

[226]  J. Wolff,et al.  Calmodulin binds to both microtubule-associated protein 2 and tau proteins. , 1984, The Journal of biological chemistry.

[227]  T D Pollard,et al.  Evidence for actin filament-microtubule interaction mediated by microtubule-associated proteins , 1978, The Journal of cell biology.

[228]  K. Weber,et al.  Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues , 1978, Cell.

[229]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[230]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[231]  J. Francon,et al.  Microtubule Assembly in vitro , 1977 .

[232]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[233]  C. Cantor,et al.  Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. , 1974, Journal of molecular biology.

[234]  R C Weisenberg,et al.  Microtubule Formation in vitro in Solutions Containing Low Calcium Concentrations , 1972, Science.

[235]  M. Kidd Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.

[236]  J. Ávila,et al.  Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein. , 2009, Journal of Alzheimer's disease : JAD.

[237]  P. Calissano,et al.  In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease , 2008, The Cerebellum.

[238]  I. Grundke‐Iqbal,et al.  Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. , 2008, Journal of Alzheimer's disease : JAD.

[239]  A. Andreadis Misregulation of tau alternative splicing in neurodegeneration and dementia. , 2006, Progress in molecular and subcellular biology.

[240]  A. Baró,et al.  Characterization by atomic force microscopy of Alzheimer paired helical filaments under physiological conditions. , 2004, Biophysical journal.

[241]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[242]  P. Baas,et al.  Slow axonal transport and the genesis of neuronal morphology. , 2004, Journal of neurobiology.

[243]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[244]  F. Leuven,et al.  Axonal transport, tau protein, and neurodegeneration in Alzheimer’s disease , 2002, NeuroMolecular Medicine.

[245]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[246]  L. Cassimeris,et al.  Regulation of microtubule-associated proteins. , 2001, International review of cytology.

[247]  M. Radeke,et al.  Fibers of tau fragments, but not full length tau, exhibit a cross β‐structure: Implications for the formation of paired helical filaments , 2000, Protein science : a publication of the Protein Society.

[248]  L. Binder,et al.  Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.

[249]  J. Brion,et al.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. , 1985, Journal of submicroscopic cytology.

[250]  J. S. Whitaker,et al.  Evidence for Anomalous Lepton Production in e+ - e- Annihilation , 1975 .